Arkolith/Insider Trading/AYTU/Form 4

Pyszczymuka Greg

Chief Commerical OfficerAYTU BIOPHARMA, INC (AYTU) · full profile →Form 4 · filed Jun 20, 2023
Net Buying
Open-Market Buys
$22K
Open-Market Sells
$0
Net Open-Market Flow
$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2023Buy(P)12K$1.87$22K22K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-23-000137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML